Literature DB >> 18989626

Interaction force diagrams: new insight into ligand-receptor binding.

Hooman Shadnia1, James S Wright, James M Anderson.   

Abstract

A method is described to calculate and visualize the interaction forces of ligand-receptor complexes. Starting from an X-ray crystallographic structure, a "thawing" procedure results in a force-field energy-minimized geometry which is close to the crystallographic starting point. By subtracting non-bonded interactions of the ligand with each amino acid residue and using the resulting force vectors to describe the slope of the remaining potential, two types of interaction force diagrams are created; the first shows the direction of the force vectors in 3D and the second shows the magnitude of the force vectors. The latter representation leads to definition of an 'Interaction Force Fingerprint' (IFFP) which is characteristic of the ligand-receptor binding. IFFPs are used to discuss ligand binding in the human estrogen receptors ERalpha and ERbeta, and provide new insight into ligand selectivity between receptor isoforms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18989626     DOI: 10.1007/s10822-008-9250-3

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  18 in total

1.  Nuclear receptor-DNA binding specificity: A COMBINE and Free-Wilson QSAR analysis.

Authors:  S Tomic; L Nilsson; R C Wade
Journal:  J Med Chem       Date:  2000-05-04       Impact factor: 7.446

Review 2.  Generalized born models of macromolecular solvation effects.

Authors:  D Bashford; D A Case
Journal:  Annu Rev Phys Chem       Date:  2000       Impact factor: 12.703

3.  Automated analysis of interatomic contacts in proteins.

Authors:  V Sobolev; A Sorokine; J Prilusky; E E Abola; M Edelman
Journal:  Bioinformatics       Date:  1999-04       Impact factor: 6.937

4.  Amino acid substitution matrices from protein blocks.

Authors:  S Henikoff; J G Henikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

5.  Chemometrical identification of mutations in HIV-1 reverse transcriptase conferring resistance or enhanced sensitivity to arylsulfonylbenzonitriles.

Authors:  Fátima Rodríguez-Barrios; Federico Gago
Journal:  J Am Chem Soc       Date:  2004-03-10       Impact factor: 15.419

6.  Comparison of protein active site structures for functional annotation of proteins and drug design.

Authors:  Robert Powers; Jennifer C Copeland; Katherine Germer; Kelly A Mercier; Viswanathan Ramanathan; Peter Revesz
Journal:  Proteins       Date:  2006-10-01

7.  Molecular basis of agonism and antagonism in the oestrogen receptor.

Authors:  A M Brzozowski; A C Pike; Z Dauter; R E Hubbard; T Bonn; O Engström; L Ohman; G L Greene; J A Gustafsson; M Carlquist
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

8.  3D-QSAR methods on the basis of ligand-receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands.

Authors:  J J Lozano; M Pastor; G Cruciani; K Gaedt; N B Centeno; F Gago; F Sanz
Journal:  J Comput Aided Mol Des       Date:  2000-05       Impact factor: 3.686

9.  Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 4: functionalization of the benzopyran A-ring.

Authors:  Bryan H Norman; Timothy I Richardson; Jeffrey A Dodge; Lance A Pfeifer; Gregory L Durst; Yong Wang; Jim D Durbin; Venkatesh Krishnan; Sean R Dinn; Shengquan Liu; John E Reilly; Kendal T Ryter
Journal:  Bioorg Med Chem Lett       Date:  2007-07-13       Impact factor: 2.823

10.  Structure-based design of estrogen receptor-beta selective ligands.

Authors:  Eric S Manas; Rayomand J Unwalla; Zhang B Xu; Michael S Malamas; Chris P Miller; Heather A Harris; Chulai Hsiao; Tatos Akopian; Wah-Tung Hum; Karl Malakian; Scott Wolfrom; Ashok Bapat; Ramesh A Bhat; Mark L Stahl; William S Somers; Juan C Alvarez
Journal:  J Am Chem Soc       Date:  2004-11-24       Impact factor: 15.419

View more
  4 in total

1.  iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis.

Authors:  Kai-Cheng Hsu; Yen-Fu Chen; Shen-Rong Lin; Jinn-Moon Yang
Journal:  BMC Bioinformatics       Date:  2011-02-15       Impact factor: 3.169

2.  Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor.

Authors:  Diego Dal Ben; Michela Buccioni; Catia Lambertucci; Ajiroghene Thomas; Rosaria Volpini
Journal:  In Silico Pharmacol       Date:  2013-12-20

3.  In silico Description of LAT1 Transport Mechanism at an Atomistic Level.

Authors:  Luca Palazzolo; Chiara Parravicini; Tommaso Laurenzi; Uliano Guerrini; Cesare Indiveri; Elisabetta Gianazza; Ivano Eberini
Journal:  Front Chem       Date:  2018-08-24       Impact factor: 5.221

4.  Discovery of novel low-molecular-weight HIV-1 inhibitors interacting with cyclophilin A using in silico screening and biological evaluations.

Authors:  Yu-Shi Tian; Chris Verathamjamras; Norihito Kawashita; Kousuke Okamoto; Teruo Yasunaga; Kazuyoshi Ikuta; Masanori Kameoka; Tatsuya Takagi
Journal:  J Mol Model       Date:  2012-09-05       Impact factor: 1.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.